Anika Therapeutics, Inc. Balance Sheet
ANIK|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$190M
FY2025
Cash
$57M
Cash and equivalents
Total Debt
N/A
FY2025
Shareholder Equity
$143M
FY2025
Anika Therapeutics, Inc. had $190M in total assets and $143M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $57.5M | $55.6M | $68.7M | $86.3M | $94.4M | $157.5M | $89.0M | $104.3M | $110.7M | $100.2M | $63.3M | $44.1M | $35.8M | $28.2M | $24.4M |
| Accounts Receivable | $23.7M | $23.6M | $26.4M | $34.6M | $29.8M | $23.1M | $23.1M | $20.8M | $23.8M | $27.6M | $21.7M | $17.2M | $18.7M | $21.5M | $17.3M |
| Inventory | $18.8M | $23.8M | $24.4M | $39.8M | $36.0M | $22.0M | $22.0M | $21.3M | $22.0M | $16.0M | $14.9M | $12.4M | $11.0M | $8.3M | $7.3M |
| Current Assets | $103.4M | $113.7M | $163.3M | $169.5M | $168.5M | $234.3M | $234.3M | $202.9M | $206.3M | $170.4M | $176.4M | $139.0M | $94.6M | $77.4M | $64.1M |
| PP&E (Net) | $40.3M | $39.0M | $37.4M | $48.3M | $47.6M | $50.8M | $50.8M | $54.1M | $56.2M | $52.3M | $40.1M | $31.7M | $32.9M | $35.1M | $36.5M |
| Goodwill | $8.1M | $7.1M | $7.6M | $7.8M | $8.4M | $7.9M | $7.9M | $8.2M | $8.2M | $7.5M | $8.3M | $9.4M | $9.1M | $8.9M | $8.9M |
| Total Assets | $190.3M | $202.7M | $270.6M | $349.1M | $347.5M | $330.7M | $330.7M | $279.0M | $282.6M | $240.2M | $235.7M | $194.0M | $156.0M | $142.1M | $132.8M |
| Current Liabilities | $21.9M | $23.3M | $31.1M | $27.9M | $29.8M | $16.3M | $16.3M | $11.3M | $13.1M | $8.8M | $17.3M | $6.0M | $9.3M | $14.5M | $14.5M |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | $9.6M | $9.6M |
| Shareholders' Equity | $143.5M | $154.0M | $212.3M | $272.4M | $288.4M | $263.5M | $263.5M | $222.8M | $210.8M | $178.1M | $135.6M | $108.9M | $94.8M | $85.2M | $82.1M |